At a glance
What is vitamin D’s role during perimenopause?
Perimenopause is the time leading up to menopause, when levels of hormones made by the ovaries rise and fall and periods may change. Vitamin D remains involved in calcium handling, bone renewal and other cell functions. It does not replace the hormones that are changing.
Why does bone health matter during perimenopause?
Changes in oestrogen, a sex hormone, can speed up bone turnover, the process of removing and replacing bone tissue. Vitamin D helps the body absorb calcium, but its role in mineral balance does not mean it can prevent all bone loss.
Do links with sleep and stress prove that vitamin D relieves perimenopausal symptoms?
No. A link with a process involving cells or hormones does not establish relief from hot flushes, sleep problems or mood changes. This article describes how the body works and does not demonstrate that extra vitamin D treats those symptoms.
Read the full article below ↓How vitamin D fits into the perimenopausal transition
Perimenopause is a transitional life stage marked by fluctuating ovarian hormone production rather than a single hormonal decline. Oestrogen, progesterone, and related signalling systems become more variable, creating downstream effects on metabolism, bone turnover, sleep regulation, mood, and inflammatory balance. Vitamin D does not control perimenopause, but it participates in the physiological systems that help the body adapt to this period of instability.
Rather than representing a disease state, perimenopause reflects a phase of biological recalibration. Vitamin D functions within this context as a regulatory signal that supports system coordination, tissue responsiveness, and metabolic resilience during change. Understanding its role requires a whole-system view rather than symptom-based thinking.
Hormonal fluctuation and regulatory strain
Perimenopause is characterised by irregular ovarian signalling, with cycles that may be anovulatory, shortened, or prolonged. These changes alter feedback loops involving the hypothalamus and pituitary, placing greater demand on endocrine coordination. Vitamin D participates in hormonal environments described in life stage hormonal transitions.
Because vitamin D receptors are present in multiple endocrine tissues, vitamin D signalling contributes to how hormonal messages are received rather than determining hormone output directly. Its role is supportive and contextual, helping stabilise signalling environments during fluctuation.
Endocrine crosstalk during perimenopause
As ovarian hormone predictability decreases, reliance on broader endocrine coordination increases. The adrenal system, thyroid signalling, and metabolic hormones often compensate unevenly. Vitamin D participates in these integrated pathways through mechanisms described in endocrine system coordination.
This helps explain why perimenopause can present differently between individuals. Vitamin D does not “fix” hormonal change, but it supports the biological conversation between systems adjusting to new signalling patterns.
Stress physiology and HPA axis load
Many individuals experience heightened stress sensitivity during perimenopause. Cortisol rhythms may flatten or become exaggerated, and recovery from stress can slow. Vitamin D contributes to environments that influence HPA axis regulation, as outlined in stress response regulation.
This interaction is indirect but important. When stress signalling becomes dominant, it can further disrupt sleep, metabolic control, and inflammatory balance. Vitamin D helps maintain regulatory tone within these stress-responsive systems.
Sleep, circadian disruption, and recovery
Sleep fragmentation and altered circadian timing are common during perimenopause. Night sweats, early waking, and reduced sleep efficiency place strain on recovery processes. Vitamin D participates in biological timing systems linked to circadian rhythm stability.
Circadian misalignment affects hormone secretion, glucose handling, and immune regulation. Vitamin D does not regulate sleep directly, but it supports the signalling environments that allow circadian systems to remain synchronised.
Bone remodelling acceleration
Bone turnover often accelerates during perimenopause due to fluctuating oestrogen signalling. Periods of increased resorption may precede measurable bone loss. Vitamin D contributes to skeletal regulation through pathways described in bone turnover regulation.
This role is closely linked to mineral handling and endocrine feedback rather than isolated bone density metrics. Early perimenopause is therefore a biologically relevant window for understanding long-term skeletal trajectories.
Calcium and phosphate handling
Hormonal variability affects how calcium is absorbed, retained, and mobilised. Vitamin D supports coordinated mineral regulation through mechanisms described in calcium handling physiology.
During perimenopause, the same calcium intake may produce different physiological outcomes depending on hormonal context, renal handling, and vitamin D signalling efficiency.
Inflammatory signalling shifts
Low-grade inflammatory tone may rise during perimenopause, partly due to hormonal fluctuation and stress system activation. Vitamin D participates in signalling environments that influence immune balance and tissue responses, as outlined in inflammatory signalling balance.
This does not imply that vitamin D suppresses inflammation, but rather that it helps regulate proportional responses within complex immune networks.
Metabolic flexibility and body composition
Changes in fat distribution and insulin sensitivity are frequently reported during perimenopause. Vitamin D participates in metabolic signalling environments described in metabolic flexibility.
Because vitamin D is stored in adipose tissue and involved in energy regulation pathways, shifts in body composition can alter both availability and responsiveness without changing intake.
Interpreting vitamin D status during transition
Blood vitamin D measurements during perimenopause must be interpreted cautiously. Fluctuating hormones, changing body composition, and altered tissue responsiveness can decouple measured levels from biological effect. This distinction is central to vitamin D status interpretation.
The same numeric value may represent different functional realities before, during, and after the perimenopausal transition.
Nutrient networks and supportive context
Vitamin D functions within a wider nutrient ecosystem that includes magnesium, calcium, protein, and vitamin K. These interactions are part of whole-system nutrient interactions.
Restrictive diets, appetite changes, or gastrointestinal sensitivity during perimenopause can therefore influence vitamin D biology indirectly through nutrient availability and utilisation.
Perimenopause within ageing biology
Perimenopause is a phase within the broader arc of ageing physiology, but it is distinct from later postmenopausal biology. Vitamin D interactions during this period overlap with themes discussed in age-related physiological change.
Recognising perimenopause as a transitional window rather than an endpoint helps frame vitamin D’s role appropriately.
Individual variability and adaptation
Responses to perimenopause vary widely. Genetics, stress exposure, activity level, diet, and prior hormonal history all shape how systems adapt. Vitamin D contributes to adaptive capacity rather than driving outcomes directly.
This variability explains why uniform recommendations often fail to capture lived experience during this stage.
A systems-based perspective
Perimenopause illustrates how human physiology operates through networks rather than single hormones or nutrients. Vitamin D participates as a regulatory signal that supports coordination, timing, and resilience across systems undergoing recalibration.
Understanding this role helps avoid reductionist conclusions and reinforces the value of physiology-first interpretation during complex life transitions.
Perimenopause and tissue responsiveness
During perimenopause, tissues may respond differently to the same hormonal and nutritional signals than they did earlier in life. This is not due to a single deficiency or failure, but to changing receptor sensitivity and intracellular signalling dynamics. Vitamin D operates within this shifting landscape, where responsiveness can matter as much as availability.
Neuroendocrine integration and symptom perception
Perimenopause often alters how signals from the nervous system and endocrine system are integrated. Changes in temperature regulation, mood perception, and sensory thresholds reflect this altered integration. Vitamin D participates in neuroendocrine environments that influence how these signals are processed, contributing to stability rather than symptom suppression.
Musculoskeletal adaptation during transition
Muscle strength, connective tissue elasticity, and joint comfort may change during perimenopause. These shifts reflect both hormonal fluctuation and altered recovery capacity. Vitamin D supports musculoskeletal signalling environments that help tissues adapt to changing mechanical and metabolic demands during this phase.
Immune balance and recovery capacity
Recovery from illness, exercise, or stress may feel slower during perimenopause. This reflects changes in immune signalling and repair processes rather than immune failure. Vitamin D contributes to immune regulation contexts that support proportional responses and effective resolution, helping maintain resilience during physiological transition.
Preparing for postmenopausal physiology
Perimenopause represents a preparatory phase rather than an endpoint. The way systems adapt during this period influences later postmenopausal biology. Vitamin D’s role during perimenopause is therefore less about immediate outcomes and more about supporting coordinated adjustment across systems as the body moves into its next long-term state.
Sleep regulation during perimenopause
Sleep architecture often changes during perimenopause, with increased night waking and altered circadian signalling. These shifts are driven by neuroendocrine changes rather than behavioural factors alone. Vitamin D participates in signalling environments linked to sleep: wake regulation and recovery processes, helping support alignment between hormonal rhythms and restorative sleep.
Metabolic signalling and energy perception
Many individuals notice changes in energy levels and metabolic efficiency during perimenopause. These changes reflect altered hormonal signalling rather than reduced capacity. Vitamin D contributes to metabolic communication pathways that influence how energy availability, utilisation, and recovery are perceived across tissues during this transition phase.
Related reading
Vitamin D and Vitamin K in Calcium Handling, Bone and Vascular Physiology: Evidence Synthesis
Evidence synthesis integrating vitamin D, vitamin K-dependent proteins, calcium handling, bone outcomes and vascular calcification evidence.
Read more →Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal
The present study aimed to investigate 25-hydroxyvitamin D [25(OH) D] improvement and calcium-phosphate metabolism in Chinese PMO patients treated with 70 mg of alendronate sodium and 5600 IU of vitamin D3 (ALN/D5600).
Original paper ↗Read more →Cardiometabolic Indices after Weight Loss with Calcium or Dairy Foods: Secondary Analyses from a Randomized Trial with Overweight/Obese Postmenopausal Women
This analysis included blood pressure (BP), and serum triglycerides, lipids (including apoproteins Apo1 and ApoB), adipokines, and C-reactive protein in n = 97 participants who finished with complete data points.
Original paper ↗Read more →Effect of Denosumab on Bone Density in Postmenopausal Osteoporosis: A Comparison with and without Calcium Supplementation in Patients on Standard Diets in Korea
We retrospectively evaluated 189 postmenopausal osteoporosis patients treated with denosumab for 12 months.
Original paper ↗Read more →Effect of regular resistance exercise, vitamin D, and calcium supplements on the bone mineral content and density in postmenopausal model of rats: An experimental study
Finally, the tail, hip, and lumbar bone mineral content, bone mineral density, bone thickness, and bone cells were evaluated in each group.
Original paper ↗Read more →Effects of Combined Exercise and Calcium/Vitamin D Supplementation on Bone Mineral Density in Postmenopausal Women: A Systematic Review and Meta-Analysis
Background: Postmenopausal osteoporosis (PMO) is a major cause of fragility fractures worldwide.
Original paper ↗Read more →Effects of Eggshell Calcium: and Vitamin D-Fortified HMR Combined with Aerobic Exercise on Bone Mineral Density in Postmenopausal Women: A Pilot Randomized Controlled Trial
Background/Objectives: Adequate calcium and vitamin D intake, along with regular physical activity, is essential for maintaining skeletal health in postmenopausal women.
Original paper ↗Read more →Eldecalcitol and calcium supplementation in Chinese women with postmenopausal osteoporosis: a prospective observational cohort study
Hypercalcemia incidence was higher in patients with compared to without calcium supplementation, indicating that concomitant eldecalcitol and calcium should be carefully considered.
Original paper ↗Read more →Patterns of Non-adherence to Supplementation with Calcium and Vitamin D in Persistent Postmenopausal Women Are Similar at Start and 1 Year Later: A Qualitative Longitudinal Study
The study aim was to compare the overall adherence (OA) to supplementation with the fixed combination of calcium and vitamin D (Ca/D) in postmenopausal women at baseline and after 1 year, and to evaluate the fluctuation of the OA in individual months.
Original paper ↗Read more →Role of Calcium and Low-Fat Dairy Foods in Weight-Loss Outcomes Revisited: Results from the Randomized Trial of Effects on Bone and Body Composition in Overweight/Obese Postmenopausal Women
We aimed to investigate weight-loss-related outcomes during intervention with low-fat dairy foods or Ca + vitamin D supplements, both as complements to hypocaloric diets.
Original paper ↗Read more →The effect of calcium and vitamin D supplementation on obesity in postmenopausal women: secondary analysis for a large-scale, placebo controlled, double-blind, 4-year longitudinal clinical trial
The purpose of the study is to detect the effect of calcium supplementation on indices of obesity and body composition.
Original paper ↗Read more →Vitamin D and calcium supplementation in women undergoing pharmacological management for postmenopausal osteoporosis: a level I of evidence systematic review
All randomised clinical trials (RCTs) comparing two or more treatments for postmenopausal osteoporosis supplemented with vitamin D and/or calcium were accessed.
Original paper ↗Read more →Association Between Glycemic Variability and Bone Turnover and the Sema3A Signaling Pathway in Postmenopausal Women with Type 2 Diabetes Mellitus
This study evaluated relationships between glycemic variability, bone turnover markers, Sema3A pathway components, and bone mineral density in postmenopausal women with type 2 diabetes mellitus (T2DM).
Original paper ↗Read more →Bone fragility in sarcoidosis and relationships with calcium metabolism disorders: a cross sectional study on 142 patients
The objective of this study was to evaluate the risk factors for low bone mineral density (BMD) and fractures in sarcoidosis.
Original paper ↗Read more →Calcium and Vitamin D Supplementation with and Without Collagen on Bone Density and Skin Elasticity in Menopausal Women: A Randomized Controlled Study
Background/Objectives: Menopause leads to estrogen deficiency, which negatively affects bone density, skin integrity, and hair health in women.
Original paper ↗Read more →Calcium intake in health maintenance: a systematic review
The aim was to conduct a review to update requirements and desirable or harmful health effects of Ca on the current scientific evidence.
Original paper ↗Read more →Dietary Calcium Intake in Patients Evaluated for Bone Fragility, with a Focus on Women Receiving Adjuvant Endocrine Therapy for Breast Cancer: A Single-Center Cross-Sectional Study
Patients were predominantly postmenopausal women, with severe osteoporosis (43.2%) or at risk of secondary osteoporosis (40.9%); 64.8% of patients evaluated for secondary osteoporosis were women on AET for BC.
Original paper ↗Read more →Determinants of Low Bone Turnover in Type 2 Diabetes-the Role of PTH
In a cross-sectional study-design data from 110 postmenopausal women and men aged 50 to 75 years diagnosed with T2DM for at least 3 years and 92 non-diabetic controls were evaluated.
Original paper ↗Read more →Effects of 25-Hydroxyvitamin D3 Combined with Phytase and Probiotic on Calcium-Phosphorus Metabolism, Bone Development, and Growth Performance in Weaned Piglets
This study evaluated the effects of dietary 25-hydroxyvitamin D3 (25-OH-VD3) in combination with phytase and probiotics on mineral metabolism, bone development, and related molecular mechanisms in weaned piglets.
Original paper ↗Read more →The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss: a case report
Demineralisation and bone density loss during immobilisation are known phenomena.
Original paper ↗Read more →Vitamin D and Calcium Physiology
Learn how vitamin D helps regulate calcium physiology, including absorption, bone mineralisation, kidney reabsorption, and hormone-driven feedback control.
Read more →